Fight CRC Blog

Letter to Secretary Kennedy

On behalf of the colorectal cancer community including patients, families, researchers, and healthcare providers across the nation, we write to emphasize the concerns you raised in your recent appearances before...

Patient Stories: How biomarker testing impacted their cancer treatment

Tumor testing, genomic testing, biomarker testing – these are all complicated names for the same thing. Regardless of how you refer to it, biomarker testing plays an important role in...

Research to Watch at ASCO 2025

Every year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings groundbreaking research to the forefront — and this year is no exception. At ASCO 2025, several clinical trials...

Leading Cancer Orgs Express Profound Concern Over Funding Cuts

On behalf of the millions of Americans living with cancer and at risk for being diagnosed, as well as health care providers, researchers, advocates, and their communities, we express our...

United to Protect Lifesaving Screenings

As the Supreme Court prepares to hear oral arguments that could reshape the future of no-cost preventive services in the U.S., 38 leading patient advocacy groups and healthcare organizations stand...

Minimal Residual Disease (MRD) Trials

This month we feature clinical trials for colorectal cancer patients with minimal residual disease (MRD) after curative-intent treatment. MRD describes microscopic residual disease, where a very small number of cancer...